Efficacy and safety for the achievement of guideline-recommended lower low-density lipoprotein cholesterol levels: a systematic review and meta-analysis

The 2018 American Heart Association/American College of Cardiology/Multi-Society Cholesterol Guidelines recommended the addition of non-statins to statin therapy for high-risk secondary prevention patients above a low-density lipoprotein cholesterol (LDL-C) threshold of ≥70 mg/dL (1.8 mmol/L). We co...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of preventive cardiology 2022-02, Vol.28 (18), p.2001-2009
Hauptverfasser:	Khan, Safi U, Khan, Muhammad U, Virani, Salim S, Khan, Muhammad Shahzeb, Khan, Muhammad Zia, Rashid, Muhammad, Kalra, Ankur, Alkhouli, Mohamad, Blaha, Michael J, Blumenthal, Roger S, Michos, Erin D
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The 2018 American Heart Association/American College of Cardiology/Multi-Society Cholesterol Guidelines recommended the addition of non-statins to statin therapy for high-risk secondary prevention patients above a low-density lipoprotein cholesterol (LDL-C) threshold of ≥70 mg/dL (1.8 mmol/L). We compared effectiveness and safety of treatment to achieve lower (
ISSN:	2047-4873 2047-4881
DOI:	10.1093/eurjpc/zwaa093